SI0950048T1 - 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease - Google Patents
1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's diseaseInfo
- Publication number
- SI0950048T1 SI0950048T1 SI9730187T SI9730187T SI0950048T1 SI 0950048 T1 SI0950048 T1 SI 0950048T1 SI 9730187 T SI9730187 T SI 9730187T SI 9730187 T SI9730187 T SI 9730187T SI 0950048 T1 SI0950048 T1 SI 0950048T1
- Authority
- SI
- Slovenia
- Prior art keywords
- alkyl
- alkoxy
- amino
- pct
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9615335A FR2757160B1 (fr) | 1996-12-13 | 1996-12-13 | 1-phenylalkyl-1,2,3,6-tetrahydropyridines |
| EP97951323A EP0950048B1 (fr) | 1996-12-13 | 1997-12-12 | 1-phenylalkyl-1,2,3,6-tetrahydropyridines pour le traitement de la maladie d'alzheimer |
| PCT/FR1997/002286 WO1998025903A1 (fr) | 1996-12-13 | 1997-12-12 | 1-phenylalkyl-1,2,3,6-tetrahydropyridines pour le traitement de la maladie d'alzheimer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI0950048T1 true SI0950048T1 (en) | 2001-10-31 |
Family
ID=9498641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9730187T SI0950048T1 (en) | 1996-12-13 | 1997-12-12 | 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6034090A (he) |
| EP (1) | EP0950048B1 (he) |
| JP (1) | JP3881384B2 (he) |
| KR (1) | KR100560358B1 (he) |
| CN (1) | CN1129579C (he) |
| AT (1) | ATE202561T1 (he) |
| AU (1) | AU730143B2 (he) |
| BR (1) | BR9713916A (he) |
| CA (1) | CA2275353C (he) |
| CY (1) | CY2274B1 (he) |
| CZ (1) | CZ289789B6 (he) |
| DE (1) | DE69705429T2 (he) |
| DK (1) | DK0950048T3 (he) |
| EE (1) | EE03763B1 (he) |
| ES (1) | ES2160977T3 (he) |
| FR (1) | FR2757160B1 (he) |
| GR (1) | GR3036643T3 (he) |
| HK (1) | HK1023997A1 (he) |
| HU (1) | HU224347B1 (he) |
| IL (1) | IL130003A (he) |
| IS (1) | IS1969B (he) |
| NO (1) | NO312720B1 (he) |
| NZ (1) | NZ336033A (he) |
| PL (1) | PL190789B1 (he) |
| PT (1) | PT950048E (he) |
| RS (1) | RS49807B (he) |
| RU (1) | RU2189975C2 (he) |
| SI (1) | SI0950048T1 (he) |
| SK (1) | SK283331B6 (he) |
| TR (1) | TR199901291T2 (he) |
| UA (1) | UA52707C2 (he) |
| WO (1) | WO1998025903A1 (he) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2763847B1 (fr) * | 1997-05-28 | 2003-06-06 | Sanofi Sa | Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1 |
| UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| FR2832405B1 (fr) * | 2001-11-19 | 2004-12-10 | Sanofi Synthelabo | Tetrahydropyridyl-alkyl-heterocycles azotes, procede pour leur preparation et compositions pharmaceutiques les contenant |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE34545B1 (en) * | 1969-10-01 | 1975-06-11 | Continental Pharma | Amino-alcohols,their salts and process for preparing the same |
| GB1321701A (en) * | 1969-10-01 | 1973-06-27 | Continental Pharma | Amino-alcohols their salts and process for prepairing the same |
| FR2650505B1 (fr) * | 1989-08-07 | 1994-06-03 | Midy Spa | Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale |
| FR2662355B1 (fr) * | 1990-05-22 | 1994-11-10 | Sanofi Sa | Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux. |
| HU211019B (en) * | 1991-12-02 | 1995-09-28 | Richter Gedeon Vegyeszet | Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds |
-
1996
- 1996-12-13 FR FR9615335A patent/FR2757160B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-12 NZ NZ336033A patent/NZ336033A/xx unknown
- 1997-12-12 RU RU99115083/04A patent/RU2189975C2/ru not_active IP Right Cessation
- 1997-12-12 HU HU0001185A patent/HU224347B1/hu not_active IP Right Cessation
- 1997-12-12 TR TR1999/01291T patent/TR199901291T2/xx unknown
- 1997-12-12 WO PCT/FR1997/002286 patent/WO1998025903A1/fr not_active Application Discontinuation
- 1997-12-12 EE EEP199900237A patent/EE03763B1/xx not_active IP Right Cessation
- 1997-12-12 JP JP52632098A patent/JP3881384B2/ja not_active Expired - Fee Related
- 1997-12-12 ES ES97951323T patent/ES2160977T3/es not_active Expired - Lifetime
- 1997-12-12 SK SK786-99A patent/SK283331B6/sk unknown
- 1997-12-12 SI SI9730187T patent/SI0950048T1/xx unknown
- 1997-12-12 DK DK97951323T patent/DK0950048T3/da active
- 1997-12-12 IL IL13000397A patent/IL130003A/he not_active IP Right Cessation
- 1997-12-12 AU AU54893/98A patent/AU730143B2/en not_active Ceased
- 1997-12-12 UA UA99063286A patent/UA52707C2/uk unknown
- 1997-12-12 CA CA002275353A patent/CA2275353C/en not_active Expired - Fee Related
- 1997-12-12 AT AT97951323T patent/ATE202561T1/de not_active IP Right Cessation
- 1997-12-12 EP EP97951323A patent/EP0950048B1/fr not_active Expired - Lifetime
- 1997-12-12 CN CN97180581A patent/CN1129579C/zh not_active Expired - Fee Related
- 1997-12-12 PT PT97951323T patent/PT950048E/pt unknown
- 1997-12-12 DE DE69705429T patent/DE69705429T2/de not_active Expired - Fee Related
- 1997-12-12 CZ CZ19992113A patent/CZ289789B6/cs not_active IP Right Cessation
- 1997-12-12 RS YUP-243/99A patent/RS49807B/sr unknown
- 1997-12-12 PL PL334071A patent/PL190789B1/pl unknown
- 1997-12-12 BR BR9713916-5A patent/BR9713916A/pt not_active Application Discontinuation
- 1997-12-12 US US09/331,006 patent/US6034090A/en not_active Expired - Fee Related
- 1997-12-12 KR KR1019997005203A patent/KR100560358B1/ko not_active IP Right Cessation
-
1999
- 1999-06-10 IS IS5075A patent/IS1969B/is unknown
- 1999-06-11 NO NO19992869A patent/NO312720B1/no unknown
-
2000
- 2000-05-30 HK HK00103181A patent/HK1023997A1/xx not_active IP Right Cessation
-
2001
- 2001-09-18 GR GR20010401501T patent/GR3036643T3/el not_active IP Right Cessation
-
2002
- 2002-05-15 CY CY0200027A patent/CY2274B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2225746A1 (en) | 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity | |
| AU4437896A (en) | Piperidine derivatives having tachykinin antagonist activity | |
| HUP0301690A2 (hu) | Szinergikus eljárások és készítmények rák kezelésére | |
| HUT77925A (hu) | Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra | |
| PL338452A1 (en) | Novel substituted 6-phenylphenatridines | |
| FR2762514B1 (fr) | Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation | |
| BG102715A (en) | New derivatives of arylglycinamide, method for their preparation and pharmaceutical compositions containing these compounds | |
| DK0874812T3 (da) | Hidtil ukendte 2,3,5-trimethyl-4-hydroxyanilidderivater, fremstilling deraf og terapeutisk anvendelse deraf | |
| NO991384L (no) | Substituerte heterocykler som anti-tumormidler | |
| CY2274B1 (en) | 1-Phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease | |
| AU7213196A (en) | Method of treating the navicular disease in horses | |
| ATE231836T1 (de) | Anti-tumor-mittel | |
| MY120461A (en) | Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia. | |
| MY120617A (en) | Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives. | |
| PL334073A1 (en) | Diphenylalkyl tetrahydropyridines, method of obtaining them and compositions containing such compounds |